Prodrug-based approaches show substantial improvements in brain drug delivery, with some candidates showing up to 15-fold higher brain uptake and 700-fold greater potency than their parent drugs.
Getting drugs into the brain is one of the biggest hurdles in treating central nervous system (CNS) disorders. Although several therapeutic agents show promise, the blood–brain barrier (BBB) acts as a protective filter, restricting their entry into brain tissue and often preventing them from reaching therapeutic concentrations.
Could modifying existing drugs help overcome this obstacle? Prodrug technology yields a promising approach by chemically modifying parent drugs to improve their delivery across the BBB. A recent systematic review explored advances in this strategy and evaluated its potential to improve CNS drug delivery. Sara Burhan Ahmed and other researchers analyzed 32 comparative experimental studies involving in vivo and in vitro investigations. The review included relevant studies issued over the preceding 15 years to assess different prodrug strategies for improving brain drug delivery.
The findings highlighted considerable improvements in brain exposure and pharmacological activity with selected prodrug formulations compared with their parent drugs. Three notable examples illustrated the potential of this approach:
Overall, prodrug modification can address important limitations in conventional CNS drug delivery and may open novel avenues for developing therapies for neurological ailments. The prodrug approach offers an encouraging opportunity to tackle one of the biggest barriers in CNS drug development: inadequate drug penetration into the brain. Although experimental findings are encouraging, integrating these advances into routine clinical practice remains a major hurdle.
Additional studies are required to refine prodrug design and establish their safety and therapeutic potency in humans.
CNS & Neurological Disorders - Drug Targets
A Systematic Review of Recent Advances in Drug Delivery to the Central Nervous System Through Prodrug Approach
Sara Burhan Ahmed et al.
Comments (0)